Silicon, the silent engine driving biotech roadmaps
Besides advances in chemistry, it was semiconductor fabrication technologies that brought the cost of sequencing drastically down from a million dollar per genome to today’s 100 dollar. They did this by enabling higher-density reads and massive parallelization through nanowell patterning, field-effect transistor (FET)-based sensors, photonic integrated circuits, and CMOS-based image sensors.
Imec’s collaborative innovations with industry
One of the leading companies in third-generation (long-read) sequencing technologies is PacBio. Their approach is based on repeated sequencing of long reads to effectively normalize errors and deliver highly reliable and accurate results.
Recognizing the potential of silicon early on, Pacific Biosciences evolved their sequencing system from a massive, room-sized machine into a more compact, integrated, and high-throughput platform with enhanced speed and efficiency.
For this integration challenge, they turned to imec. By combining the advances in image sensor technology – featuring denser pixel arrays – with custom photonic components such as waveguides, filters, and Fresnel lenses, PacBio developed a next-generation sequencer capable of processing 2,500 genomes annually.
This system promises to reduce sequencing costs under $10 per gigabase (one billion bases), marking a significant milestone in the pursuit of affordable, scalable genomics solutions.
PacBio’s roadmap, driven by semiconductor technology.
Just like semiconductor innovations transformed DNA sequencing, they also fueled a parallel revolution in DNA synthesis, driving scalable and high-density oligonucleotide production.
Twist Bioscience revolutionized DNA synthesis by transitioning from a traditional nanowell-plate-based process to a silicon-chip-based platform. Leveraging inkjet technology, they patterned silicon chips with anchoring sites for DNA growth, achieving an impressive density of 20,000 spots (of unique oligos) per square centimeter.
As Twist Bioscience ventured into the emerging market of DNA data storage, they partnered with imec to address a critical challenge: increasing the throughput of their system.
To make DNA-based digital information storage economically viable, the throughput needed to scale by more than three orders of magnitude. Together with imec, they developed a custom ASIC chip integrated with an exceptionally dense array of electrochemical cells, all controlled by the ASIC.
Through a close collaboration, imec and Twist Bioscience succeeded in solving the technical challenges in the design and development of the ASIC. One of these challenges was the etching of the platinum electrodes at very small dimensions. Imec developed a dedicated process, tackling these and other challenges and ensuring a high-throughput, manufacturable system.
IC-Link managed the ASIC supply chain to source a customized ASIC wafer on which imec did the post-processing part in its cleanroom. Ultimately, this effort led to the successful encoding of 1 gigabyte of data in a single synthesis cycle.
Twist Bioscience translated a nanowell-based approach for DNA synthesis into a chip-based approach.
Imec’s in-house innovations
Imec's ability to think outside the box and tackle complex challenges is a key strength for its partners, complemented by an extensive expertise in process technologies and specialized features. Imec uses these assets also for in-house innovations, serving as demonstrators or potential technologies for future industry transfer.
A common thread in these innovations is their scalable and highly reproducible nature – enabled by the semiconductor platform – and their ability to enhance the performance of biological processes, measurements, or interactions.
A prime example of such in-house innovation is the newly developed sub-pixel resolution lens-free fluorescence microscope-on-chip, which utilizes structured illumination.
The current sequencing landscape is dominated by two types of sequencers:
- CMOS-based sequencers that offer compactness but are limited in the number of reads per square centimeter
- lens-based sequencers, capable of achieving billions of reads per square centimeter, but with a large form factor
The novel concept developed by imec seeks to combine the best aspects of both approaches – delivering compact, high-throughput sequencing systems.
By integrating a fully functional optical stack – incorporating filters and waveguides – directly on top of an imager chip, imec made it possible to build highly miniaturized fluorescence microscopes-on-chip with large field of view and sub-pixel resolution. They are ideally suited for applications such as genome sequencing and proteomics, that benefit from parallel readout of large and dense molecular arrays.
The concept of imec’s on-chip fluorescence microscope consisting of an imager with SiN waveguides and phase modulators on top (left) and the proof-of-concept chip (right).
A second example of imec’s in-house innovations is the work on solid-state nanopores.
Imec has developed a scalable process to mass-produce solid-state nanopores using deep UV lithography. This enables high-precision, low-variability nanopores, making them ideal for hybrid nanopore applications.
The mass producibility of these nanopores paves the way for innovations in personalized medicine, proteomics, and DNA memory, while also generating valuable data for optimizing nanopore performance.
Imec now offers a manufacturable nanopore platform and is seeking assay partners to further develop applications using its minimal viable demonstrator (MVD) – a multi-pore array with fluidics and read-out electronics.
Imec bridges the gap between flexible university fabs and high-end commercial foundries
For start-ups developing proof-of-concept technologies, the traditional commercial chip manufacturers are often inaccessible due to their high-volume requirements. Similarly, established companies may struggle to find a suitable foundry when they need highly advanced features or work with non-standard materials not supported by mainstream CMOS process flows.
University fabrication facilities present a flexible alternative, offering expertise in novel materials and advanced features. However, their infrastructure may not align with the latest commercial process flows, and their capacity for rapid prototyping and achieving a fast time-to-market is often limited by scheduling constraints and unreliable machine uptime.
Imec addresses this gap by combining the flexibility and advanced capabilities of academic environments with the cutting-edge infrastructure and commercial expertise of a high-end foundry. Moreover, imec collaborates with an extensive partner network spanning the entire semiconductor ecosystem.
This allows biotech companies to benefit not only from prototyping and low-volume manufacturing but also from a seamless transition to large-scale commercial production at foundries through process technology transfer.
Imec has a 200mm and 300mm state-of-the-art cleanroom with 24/7 operation.
Beyond R&D: imec’s mature technology platforms and process capabilities
Imec is widely recognized as a leading force in semiconductor R&D, collaborating with major industry players in large-scale ‘core CMOS’ research programs. Beyond this, imec has also developed several mature specialty technology platforms, offering fully established process flows, validated design kits, and streamlined paths to manufacturing for advanced technologies not directly accessible in large commercial foundries.
Through its state-of-the-art 200mm and 300mm cleanrooms and partner fabs, imec enables prototyping and production of specialty semiconductor devices, ensuring a seamless transition to the required volumes, from multi-project wafers (MPW) to large-scale production via major partner foundries.
These are some of the key technology platforms and capabilities:
- Integrated photonics: SOI-based wafer-scale integrated silicon photonics platform (iSiPP) and ultra-low-loss silicon nitride (ULLSiN), available on both 200mm and 300mm wafers. The platform includes a broad range of components such as waveguides, edge couplers, gratings modulators and detectors. The SiN variant is particularly suited for biotech and life sciences, supporting applications in visible-wavelength photonics.
- 3D & heterogeneous integration: offers through-silicon vias (TSVs), hybrid bonding, flip-chip, heterogeneous integration via micro-transfer printing, and wafer reconstruction, enabling highly compact and efficient semiconductor designs.
- Specialized process capabilities:
- Advanced lithography: Dry 193 and immersion 193, e-beam, EUV and nanoimprint, for optical gratings and nanopores
- Post-processing of CMOS wafers: mirrors, band pass and lenses on imagers, active apertures on CMOS, low-temperature SiN photonics, nano-scale electrode material for biology applications
- Nano-optics: transparent substrates, high-refractive index materials for flat optics and high-index waveguides, microfluidics and glass processing: glass-to-silicon fusion bonding, integrated microfluidic components.
- Micro- and nanostructures: nanotips, nanochannels, nanopores, membranes.
An overview of imec’s technology platforms, available for prototyping and volume manufacturing.
Additionally, IC-Link provides a gateway to ASIC manufacturing.IC-Link is a separate division within imec, offering end-to-end ASIC services. Leveraging imec’s semiconductor capabilities and ASIC ecosystem partnerships, IC-Link provides comprehensive support throughout the entire ASIC lifecycle.
This includes design services, prototyping, volume manufacturing, package design, assembly, supply chain management, production engineering, and failure analysis when needed.
By offering tailored solutions, IC-Link has enabled companies across various industries to bring custom ASICs from concept to production while ensuring high quality and performance.
Imec supports the full product development cycle, with dedicated divisions assisting customers in every need, from R&D and prototyping, all the way to manufacturing and supply chain management.
Want to know more?
- Read the white paper on monolithic microsystems to learn more about imec’s post-processing capabilities to build unique structures and specialty components on top of CMOS.
- Watch the recordings of the seminar ‘Disrupting bio with specialty silicon’, with imec experts from life science R&D, technology platforms, ASIC development, as well as from PacBio and Twist Bioscience.
- Discover IC-Link’s end-to-end ASIC offering and an example of collaboration with a health-tech company in this testimonial of Capri-Medical.
- Contact health@imec.be to discuss how imec can support your efforts in biotech.
